London: Intake of aspirin and omega-3 is safe and effective at reducing the chances of bowel cancer in high-risk patients, according to a new clinical trial. In the trial, these low-cost drugs reduced the number of pre-cancerous polyps — a small growth, usually benign — in patients found to be at high risk of developing bowel cancer. The findings showed that patients who took aspirin had 22 percent fewer polyps compared to those who took the placebo. Those who took omega-3, also called EPA (eicosapentaenoic acid) had 9 percent fewer polyps compared to those who took the placebo. (IANS)